HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Birgitte Brinkmann Olsen Selected Research

resorufin

11/2009Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses.
4/2009Resorufin: a lead for a new protein kinase CK2 inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD

Birgitte Brinkmann Olsen Research Topics

Disease

1DNA Damage
11/2009
1Neoplasms (Cancer)
11/2009
1Carcinoma (Carcinomatosis)
04/2009
1Colorectal Neoplasms (Colorectal Cancer)
04/2009

Drug/Important Bio-Agent (IBA)

2resorufinIBA
11/2009 - 04/2009
1Cisplatin (Platino)FDA LinkGeneric
11/2009
1Casein Kinase II (Casein Kinase 2)IBA
11/2009
1Phosphotransferases (Kinase)IBA
11/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2009